Description
Candibiotic Ear Drops are commonly prescribed for the following conditions:
- Otitis Externa
- Fungal Ear Infections
Sh7,800.00
Candibiotic Ear Drops is a combination medication that is typically used for the treatment of certain ear infections.
Candibiotic Ear Drops are commonly prescribed for the following conditions:
Settings | CANDIBIOTIC EAR DROPS remove | Aciclovir Skin Cream remove | OFLOX OZ 200\500 MG remove | AMINOPHYLINE TABLETS 100S remove | Ampiclox Syrup remove | AMBRODIL SYRP 100ml remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh7,800.00 | Sh2,000.00 | Sh7,000.00 | Sh4,000.00 | Sh2,500.00 | Sh2,500.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Candibiotic Ear Drops is a combination medication that is typically used for the treatment of certain ear infections. |
| Aminophylline tablets are a type of medicine known as a bronchodilator, which is used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect the lungs and airways. | |||
Content | Candibiotic Ear Drops are commonly prescribed for the following conditions:
| Aciclovir belongs to a class of medication known as antivirals. It works by stopping the growth of the virus. This medication does not cure herpes, and it does not prevent passing the infection to someone else. It does not prevent a future occurrence. | Used to treat:
| The main uses of Aminophylline tablets include:
| It is a powder containing Ampicillin trihydrate B.P. and Cloxacillin. When dispensed as directed each 5 ml of the suspension contains the equivalent of 125 mg Ampicillin and 125 mg Cloxacillin. It is used to treat Infections caused by susceptible organisms where a mixed infection is present and includes penicillin-resistant staphylococci. | Used for treating
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.